Neurocognitive outcomes for acute global acquired brain injury in children

Fenella J Kirkham1

  • 1aDepartment of Child Health, University Hospital Southampton, Southampton bDevelopmental Neurosciences Unit, UCL Great Ormond Street Institute of Child Health, London cClinical and Experimental Sciences, University of Southampton, Southampton, UK.

Insights

Children with acute brain injuries face significant long-term cognitive challenges, especially in processing speed and IQ. Research now highlights these persistent effects, impacting development and recovery.

Area of Science:

  • Pediatric neurology
  • Neuroscience
  • Developmental psychology

Background:

  • Acute global brain injury in children, from traumatic brain injury (TBI) or nontraumatic coma, incurs substantial costs.
  • Historically, research on long-term cognitive and behavioral outcomes in pediatric TBI has been limited.

Purpose of the Study:

  • To review current understanding of long-term cognitive and behavioral outcomes in children following acute global brain injury.
  • To synthesize findings from recent studies, including follow-up, population-based, and meta-analyses.

Main Methods:

  • Review of recent long-term follow-up studies, population-based studies, and meta-analyses concerning pediatric TBI and coma.
  • Analysis of cognitive outcomes (processing speed, working memory, IQ, attention) and diagnostic/prognostic utility of MRI.

Main Results:

  • Severe TBI in children is associated with significant cognitive deficits, particularly in processing speed, working memory, and IQ.
  • Children surviving cardiac arrest often show reduced IQ; meningitis survivors typically have normal IQ, though lower than controls.
  • Advances in encephalitis research include recognizing autoimmune and demyelinating causes; MRI shows diagnostic and potential prognostic value.

Conclusions:

  • Long-term cognitive deficits are a significant consequence of acute global brain injury in children.
  • Cognitive and MRI endpoints are crucial for evaluating interventions in clinical trials due to long follow-up times.
Abstract